[1] |
|
[2] |
|
[3] |
Thompson SL, O'Leary GH, Austelle CW, et al. A review of parameter settings for invasive and non-invasive vagus nerve stimulation (VNS) applied in neurological and psychiatric disorders[J]. Front Neurosci, 2021, 15: 709436. DOI: 10.3389/fnins.2021.709436.
|
[4] |
Frangos E, Komisaruk BR. Access to vagal projections via cutaneous electrical stimulation of the neck: fMRI evidence in healthy humans[J]. Brain Stimul, 2017, 10(1): 19-27. DOI: 10.1016/j.brs.2016.10.008.
|
[5] |
Redgrave J, Day D, Leung H, et al. Safety and tolerability of transcutaneous vagus nerve stimulation in humans; a systematic review[J]. Brain Stimul, 2018, 11(6): 1225-1238. DOI: 10.1016/j.brs.2018.08.010.
|
[6] |
Badran BW, Brown JC, Dowdle LT, et al. Tragus or cymba conchae? Investigating the anatomical foundation of transcutaneous auricular vagus nerve stimulation (taVNS)[J]. Brain Stimul, 2018, 11(4): 947-948. DOI: 10.1016/j.brs.2018.06.003.
|
[7] |
Badran BW, Dowdle LT, Mithoefer OJ, et al. Neurophysiologic effects of transcutaneous auricular vagus nerve stimulation (taVNS) via electrical stimulation of the tragus: a concurrent taVNS/fMRI study and review[J]. Brain Stimul, 2018, 11(3): 492-500. DOI: 10.1016/j.brs.2017.12.009.
|
[8] |
Kaniusas E, Kampusch S, Tittgemeyer M, et al. Current directions in the auricular vagus nerve stimulation II - an engineering perspective[J]. Front Neurosci, 2019, 13: 772. DOI: 10.3389/fnins.2019.00772.
|
[9] |
Mertens A, Raedt R, Gadeyne S, et al. Recent advances in devices for vagus nerve stimulation[J]. Expert Rev Med Devices, 2018, 15(8): 527-539. DOI: 10.1080/17434440.2018.1507732.
|
[10] |
Stefan H, Kreiselmeyer G, Kerling F, et al. Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial[J]. Epilepsia, 2012, 53(7): e115-e118. DOI: 10.1111/j.1528-1167.2012.03492.x.
|
[11] |
Aihua L, Lu S, Liping L, et al. A controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy[J]. Epilepsy Behav, 2014, 39: 105-110. DOI: 10.1016/j.yebeh.2014.08.005.
|
[12] |
He W, Jing X, Wang X, et al. Transcutaneous auricular vagus nerve stimulation as a complementary therapy for pediatric epilepsy: a pilot trial[J]. Epilepsy Behav, 2013, 28(3): 343-346. DOI: 10.1016/j.yebeh.2013.02.001.
|
[13] |
Rong P, Liu A, Zhang J, et al. Transcutaneous vagus nerve stimulation for refractory epilepsy: a randomized controlled trial[J]. Clin Sci (Lond), 2014, online ahead of print. DOI: 10.1042/CS20130518.
|
[14] |
Bauer S, Baier H, Baumgartner C, et al. Transcutaneous vagus nerve stimulation (tVNS) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial (cMPsE02)[J]. Brain Stimul, 2016, 9(3): 356-363. DOI: 10.1016/j.brs.2015.11.003.
|
[15] |
Barbella G, Cocco I, Freri E, et al. Transcutaneous vagal nerve stimulatio (t-VNS): an adjunctive treatment option for refractory epilepsy[J]. Seizure, 2018, 60: 115-119. DOI: 10.1016/j.seizure.2018.06.016.
|
[16] |
|
[17] |
Panebianco M, Zavanone C, Dupont S, et al. Vagus nerve stimulation therapy in partial epilepsy: a review[J]. Acta Neurol Belg, 2016, 116(3): 241-248. DOI: 10.1007/s13760-016-0616-3.
|
[18] |
Marrosu F, Serra A, Maleci A, et al. Correlation between GABA (A) receptor density and vagus nerve stimulation in individuals with drug-resistant partial epilepsy[J]. Epilepsy Res, 2003, 55(1-2): 59-70. DOI: 10.1016/s0920-1211(03)00107-4.
|
[19] |
Henry TR, Votaw JR, Pennell PB, et al. Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy[J]. Neurology, 1999, 52(6): 1166-1173. DOI: 10.1212/wnl.52.6.1166.
|
[20] |
Panebianco M, Zavanone C, Dupont S, et al. Vagus nerve stimulation therapy in partial epilepsy: a review[J]. Acta Neurol Belg, 2016, 116(3): 241-248. DOI: 10.1007/s13760-016-0616-3.
|
[21] |
Krahl SE, Clark KB. Vagus nerve stimulation for epilepsy: a review of central mechanisms[J]. Surg Neurol Int, 2012, 3(Suppl 4): S255-S259. DOI: 10.4103/2152-7806.103015.
|
[22] |
Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex--linking immunity and metabolism[J]. Nat Rev Endocrinol, 2012, 8(12): 743-754. DOI: 10.1038/nrendo.2012.189.
|
[23] |
Hein E, Nowak M, Kiess O, et al. Auricular transcutaneous electrical nerve stimulation in depressed patients: a randomized controlled pilot study[J]. J Neural Transm (Vienna), 2013, 120(5): 821-827. DOI: 10.1007/s00702-012-0908-6.
|
[24] |
Rong P, Liu J, Wang L, et al. Effect of transcutaneous auricular vagus nerve stimulation on major depressive disorder: a nonrandomized controlled pilot study[J]. J Affect Disord, 2016, 195: 172-179. DOI: 10.1016/j.jad.2016.02.031.
|
[25] |
Liu J, Fang J, Wang Z, et al. Transcutaneous vagus nerve stimulation modulates amygdala functional connectivity in patients with depression[J]. J Affect Disord, 2016, 205: 319-326. DOI: 10.1016/j.jad.2016.08.003.
|
[26] |
Fang J, Egorova N, Rong P, et al. Early cortical biomarkers of longitudinal transcutaneous vagus nerve stimulation treatment success in depression[J]. Neuroimage Clin, 2016, 14: 105-111. DOI: 10.1016/j.nicl.2016.12.016.
|
[27] |
Lv H, Zhao YH, Chen JG, et al. Vagus nerve stimulation for depression: a systematic review[J]. Front Psychol, 2019, 10: 64. DOI: 10.3389/fpsyg.2019.00064.
|
[28] |
Woelfer M, Kasties V, Kahlfuss S, et al. The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder[J]. Neuroscience, 2019, 403: 93-110. DOI: 10.1016/j.neuroscience.2018.03.034.
|
[29] |
Ma L, Demin KA, Kolesnikova TO, et al. Animal inflammation-based models of depression and their application to drug discovery[J]. Expert Opin Drug Discov, 2017, 12(10): 995-1009. DOI: 10.1080/17460441.2017.1362385.
|
[30] |
Liu CH, Zhang GZ, Li B, et al. Role of inflammation in depression relapse[J]. J Neuroinflammation, 2019, 16(1): 90. DOI: 10.1186/s12974-019-1475-7.
|
[31] |
Evrensel A, Ünsalver BÖ, Ceylan ME. Neuroinflammation, gut-brain axis and depression[J]. Psychiatry Investig, 2020, 17(1): 2-8. DOI: 10.30773/pi.2019.08.09.
|
[32] |
Marshall R, Taylor I, Lahr C, et al. Bioelectrical stimulation for the reduction of inflammation in inflammatory bowel disease[J]. Clin Med Insights Gastroenterol, 2015, 8: 55-59. DOI: 10.4137/CGast.S31779.
|
[33] |
Mebius RE, Kraal G. Structure and function of the spleen[J]. Nat Rev Immunol, 2005, 5(8): 606-616. DOI: 10.1038/nri1669.
|
[34] |
Merrill CA, Jonsson MA, Minthon L, et al. Vagus nerve stimulation in patients with Alzheimer's disease: additional follow-up results of a pilot study through 1 year[J]. J Clin Psychiatry, 2006, 67(8): 1171-1178. DOI: 10.4088/jcp.v67n0801.
|
[35] |
Liu AF, Zhao FB, Wang J, et al. Effects of vagus nerve stimulation on cognitive functioning in rats with cerebral ischemia reperfusion[J]. J Transl Med, 2016, 14: 101. DOI: 10.1186/s12967-016-0858-0.
|
[36] |
Clark KB, Naritoku DK, Smith DC, et al. Enhanced recognition memory following vagus nerve stimulation in human subjects[J]. Nat Neurosci, 1999, 2(1): 94-98. DOI: 10.1038/4600.
|
[37] |
Sun L, Peräkylä J, Holm K, et al. Vagus nerve stimulation improves working memory performance[J]. J Clin Exp Neuropsychol, 2017, 39(10): 954-964. DOI: 10.1080/13803395.2017.1285869.
|
[38] |
Desbeaumes Jodoin V, Richer F, Miron JP, et al. Long-term sustained cognitive benefits of vagus nerve stimulation in refractory depression[J]. J ECT, 2018, 34(4): 283-290. DOI: 10.1097/YCT.0000000000000502.
|
[39] |
|
[40] |
|
[41] |
Huffman WJ, Subramaniyan S, Rodriguiz RM, et al. Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice[J]. Brain Stimul, 2019, 12(1): 19-29. DOI: 10.1016/j.brs.2018.10.005.
|
[42] |
Martlé V, Raedt R, Waelbers T, et al. The effect of vagus nerve stimulation on CSF monoamines and the PTZ seizure threshold in dogs[J]. Brain Stimul, 2015, 8(1): 1-6. DOI: 10.1016/j.brs.2014.07.032.
|
[43] |
Raedt R, Clinckers R, Mollet L, et al. Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model[J]. J Neurochem, 2011, 117(3): 461-469. DOI: 10.1111/j.1471-4159.2011.07214.x.
|
[44] |
Van Leusden JW, Sellaro R, Colzato LS. Transcutaneous Vagal Nerve Stimulation (tVNS): a new neuromodulation tool in healthy humans?[J]. Front Psychol, 2015, 6: 102. DOI: 10.3389/fpsyg.2015.00102.
|
[45] |
Broncel A, Bocian R, Klos-Wojtczak P, et al. Vagal nerve stimulation as a promising tool in the improvement of cognitive disorders[J]. Brain Res Bull, 2020, 155: 37-47. DOI: 10.1016/j.brainresbull.2019.11.011.
|
[46] |
Gebhardt N, Bär KJ, Boettger MK, et al. Vagus nerve stimulation ameliorated deficits in one-way active avoidance learning and stimulated hippocampal neurogenesis in bulbectomized rats[J]. Brain Stimul, 2013, 6(1): 78-83. DOI: 10.1016/j.brs.2012.01.009.
|
[47] |
|
[48] |
Fornai F, Ruffoli R, Giorgi FS, et al. The role of locus coeruleus in the antiepileptic activity induced by vagus nerve stimulation[J]. Eur J Neurosci, 2011, 33(12): 2169-2178. DOI: 10.1111/j.1460-9568.2011.07707.x.
|
[49] |
|
[50] |
Manta S, El Mansari M, Debonnel G, et al. Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems[J]. Int J Neuropsychopharmacol, 2013, 16(2): 459-470. DOI: 10.1017/S1461145712000387.
|
[51] |
Neese SL, Sherill LK, Tan AA, et al. Vagus nerve stimulation may protect GABAergic neurons following traumatic brain injury in rats: an immunocytochemical study[J]. Brain Res, 2007, 1128(1): 157-163. DOI: 10.1016/j.brainres.2006.09.073.
|
[52] |
Shi C, Flanagan SR, Samadani U. Vagus nerve stimulation to augment recovery from severe traumatic brain injury impeding consciousness: a prospective pilot clinical trial[J]. Neurol Res, 2013, 35(3): 263-276. DOI: 10.1179/1743132813Y.0000000167.
|
[53] |
|
[54] |
|
[55] |
|